Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.400
-0.280 (-5.98%)
At close: Dec 5, 2025, 4:00 PM EST
4.470
+0.070 (1.59%)
After-hours: Dec 5, 2025, 4:47 PM EST

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
248152326112206262
Market Cap Growth
26.42%-53.41%191.65%-45.72%-21.31%-
Enterprise Value
16987229193--
Last Close Price
4.404.009.139.9810.0812.81
PS Ratio
65.2257.64118.2431.67-263.6045.94
PB Ratio
5.684.614.802.13-10.4290.02
P/TBV Ratio
5.684.614.802.13--
EV/Sales Ratio
59.8532.9782.9654.51--
Debt / Equity Ratio
0.370.500.030.23-0.293.25
Asset Turnover
0.030.030.030.07--
Inventory Turnover
0.661.280.881.232.91-
Quick Ratio
4.644.137.824.520.902.50
Current Ratio
4.734.277.954.560.932.52
Return on Equity (ROE)
-166.97%-120.84%-81.47%-205.22%--
Return on Assets (ROA)
-52.21%-46.90%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-87.22%-67.42%-48.00%-81.16%--
Return on Capital Employed (ROCE)
-89.40%-107.20%-61.30%-42.40%-1693.80%-79.00%
Earnings Yield
-30.23%-40.13%-15.05%-30.04%-11.16%-8.15%
FCF Yield
-24.47%-33.44%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-15.74%-10.82%-121.67%-609.97%-4.86%-
Source: S&P Capital IQ. Standard template. Financial Sources.